论文信息 - Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study - 字舞流文

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study

R. Greil | G. Salles | P. Zinzani | M. Winderlich | Kibum Kim | I. Fleury | S. Ambarkhane | G. Hess | J. Trotman | G. Nowakowski | A. Peters | D. Yoon | R. Marks | P. Mondello | E. Joffe | Dan-chi Huang | E. Waltl | M. Ku | N. Kurukulasuriya | Eva E. Waltl